Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus labetalol versus saline for hemodynamic response to laryngoscopy and intubation
IRCT20160812029310N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexmedetomidine and labetalol (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Mean heart rate, Mean arterial pressure and 6 more. Started May 2018; status: completed.
02
Drugs
dexmedetomidinelabetalol
Beyond the preview
Go deeper on IRCT20160812029310N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160812029310N3.